These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22431310)

  • 21. New BODIPY derivatives as OFF-ON fluorescent chemosensor and fluorescent chemodosimeter for Cu2+: cooperative selectivity enhancement toward Cu2+.
    Qi X; Jun EJ; Xu L; Kim SJ; Hong JS; Yoon YJ; Yoon J
    J Org Chem; 2006 Mar; 71(7):2881-4. PubMed ID: 16555847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligonucleotide labeling using BODIPY phosphoramidite.
    Tram K; Twohig D; Yan H
    Nucleosides Nucleotides Nucleic Acids; 2011 Jan; 30(1):1-11. PubMed ID: 21259159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-labeled fluorescent ligands for the mu opioid receptor.
    Emmerson PJ; Archer S; El-Hamouly W; Mansour A; Akil H; Medzihradsky F
    Biochem Pharmacol; 1997 Dec; 54(12):1315-22. PubMed ID: 9393674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of on-off or off-on fluorescent and optical [Cu²⁺] and [Hg²⁺] responses via formal Me/H substitution in fully characterized thienyl "scorpionate"-like BODIPY systems.
    Kim K; Choi SH; Jeon J; Lee H; Huh JO; Yoo J; Kim JT; Lee CH; Lee YS; Churchill DG
    Inorg Chem; 2011 Jun; 50(12):5351-60. PubMed ID: 21598961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tunable design strategy for fluorescence probes based on 4-substituted BODIPY chromophore: improvement of highly sensitive fluorescence probe for nitric oxide.
    Gabe Y; Ueno T; Urano Y; Kojima H; Nagano T
    Anal Bioanal Chem; 2006 Oct; 386(3):621-6. PubMed ID: 16924384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Galactosidase-Activatable Fluorescent Probe for Detection of Bacteria Based on BODIPY.
    Chen X; Liu YC; Cui JJ; Wu FY; Xiao Q
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilicides-small molecules targeting bacterial virulence.
    Aberg V; Almqvist F
    Org Biomol Chem; 2007 Jun; 5(12):1827-34. PubMed ID: 17551629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystallographic, photophysical, NMR spectroscopic and reactivity manifestations of the "8-heteroaryl effect" in 4,4-difluoro-8-(C(4)H(3)X)-4-bora-3a,4a-diaza-s-indacene (X = O, S, Se) (BODIPY) systems.
    Kim K; Jo C; Easwaramoorthi S; Sung J; Kim DH; Churchill DG
    Inorg Chem; 2010 Jun; 49(11):4881-94. PubMed ID: 20420417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facile syntheses of BODIPY derivatives for fluorescent labeling of the 3' and 5' ends of RNAs.
    Ikawa Y; Moriyama S; Furuta H
    Anal Biochem; 2008 Jul; 378(2):166-70. PubMed ID: 18455995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilicides regulate pili expression in E. coli without affecting the functional properties of the pilus rod.
    Aberg V; Fällman E; Axner O; Uhlin BE; Hultgren SJ; Almqvist F
    Mol Biosyst; 2007 Mar; 3(3):214-8. PubMed ID: 17308668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.
    Baker JG; Adams LA; Salchow K; Mistry SN; Middleton RJ; Hill SJ; Kellam B
    J Med Chem; 2011 Oct; 54(19):6874-87. PubMed ID: 21870877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and characterization of a fluorescent probe for α-tocopherol suitable for fluorescence microscopy.
    Ghelfi M; Ulatowski L; Manor D; Atkinson J
    Bioorg Med Chem; 2016 Jun; 24(12):2754-61. PubMed ID: 27161877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilicide ec240 disrupts virulence circuits in uropathogenic Escherichia coli.
    Greene SE; Pinkner JS; Chorell E; Dodson KW; Shaffer CL; Conover MS; Livny J; Hadjifrangiskou M; Almqvist F; Hultgren SJ
    mBio; 2014 Oct; 5(6):e02038. PubMed ID: 25352623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and properties of novel fluorescent switches.
    Golovkova TA; Kozlov DV; Neckers DC
    J Org Chem; 2005 Jul; 70(14):5545-9. PubMed ID: 15989336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational design, synthesis, and spectroscopic and photophysical properties of a visible-light-excitable, ratiometric, fluorescent near-neutral pH indicator based on BODIPY.
    Boens N; Qin W; Baruah M; De Borggraeve WM; Filarowski A; Smisdom N; Ameloot M; Crovetto L; Talavera EM; Alvarez-Pez JM
    Chemistry; 2011 Sep; 17(39):10924-34. PubMed ID: 21932233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene as a bright fluorescent label for DNA.
    Ehrenschwender T; Wagenknecht HA
    J Org Chem; 2011 Apr; 76(7):2301-4. PubMed ID: 21381720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carboxyl BODIPY dyes from bicarboxylic anhydrides: one-pot preparation, spectral properties, photostability, and biolabeling.
    Wang D; Fan J; Gao X; Wang B; Sun S; Peng X
    J Org Chem; 2009 Oct; 74(20):7675-83. PubMed ID: 19772337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-Terminal properties are important for ring-fused 2-pyridones that interfere with the chaperone function in uropathogenic E. coli.
    Aberg V; Hedenström M; Pinkner JS; Hultgren SJ; Almqvist F
    Org Biomol Chem; 2005 Nov; 3(21):3886-92. PubMed ID: 16240004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New 4,4-difluoro-3alpha,4alpha-diaza-s-indacene (BODIPY) labeled sphingolipids for membrane studies].
    Boldyrev IA; Molotkovskiĭ IuG
    Bioorg Khim; 2010; 36(4):547-51. PubMed ID: 20823923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of highly fluorescent BODIPY-based nanocars.
    Godoy J; Vives G; Tour JM
    Org Lett; 2010 Apr; 12(7):1464-7. PubMed ID: 20210334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.